[1]
J. K. Galazka, A. Polak, and B. Matyjaszek-Matuszek, “Adiponectin as a novel predictive biomarker of multiple sclerosis course”, Curr. Issues Pharm. Med. Sci., vol. 36, no. 2, pp. 99–102, Jun. 2023, doi: 10.2478/cipms-2023-0017.